Furthermore, TGF-β enhances the epithelial-to-mesenchymal transition (EMT), synergistically triggering tumor metastasis with IL-6 via the overactivation of JAK/STAT signaling pathways [107]. The gene discussed is TGFB1; the disease is neoplasm.